AUA 2024: Back to Medical School: Immunology in NMIBC and Neoadjuvant MIBC for the Urologist urotoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from urotoday.com Daily Mail and Mail on Sunday newspapers.
IRVINE, Calif., March 28, 2024 (GLOBE NEWSWIRE) CG Oncology, Inc. (NASDAQ: CGON), a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients
Bladder cancer is more aggressive and advanced in South Texas, study shows
Bladder cancer is more aggressive and more advanced in South Texas residents than in many parts of the country, a study by the Mays Cancer Center, home to UT Health San Antonio MD Anderson, indicates.
The disease is also deadlier in Latinos and women, regardless of where they live nationwide, according to the research.
The team from The University of Texas Health Science Center at San Antonio (UT Health San Antonio), which includes the Mays Cancer Center, compared bladder cancer cases in the Texas Cancer Registry with cases in the Surveillance, Epidemiology and End Results (SEER) Program. SEER, which collects data on cancer cases from various locations and sources across the U.S., does not include Texas statistics.
E-Mail
IMAGE: Dr. Shenghui Wu, faculty researcher at The University of Texas Health Science Center at San Antonio, led an analysis of bladder cancer incidence and five-year survival, comparing cases in South. view more
Credit: The University of Texas Health Science Center at San Antonio
Bladder cancer is more aggressive and more advanced in South Texas residents than in many parts of the country, a study by the Mays Cancer Center, home to UT Health San Antonio MD Anderson, indicates.
The disease is also deadlier in Latinos and women, regardless of where they live nationwide, according to the research.
The team from The University of Texas Health Science Center at San Antonio (UT Health San Antonio), which includes the Mays Cancer Center, compared bladder cancer cases in the Texas Cancer Registry with cases in the Surveillance, Epidemiology and End Results (SEER) Program. SEER, which collects data on cancer cases from various locations and sources across the U.S.,